F7Y.F Gaush Meditech Ltd
- Market cap
- EUR 80.6M
- P/E
- 9.1x
- P/B
- 0.36x
- ROE
- 5.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is F7Y.F undervalued?
Graham numberF7Y.F trades 62.1% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Gaush Meditech Ltd fundamental analysis
No fundamental analysis for Gaush Meditech Ltd yet.
Gaush Meditech Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Gaush Meditech Ltd
Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, t…
Full company profileGaush Meditech Ltd financial statements
Gaush Meditech Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.30B | 1.25B | 1.41B | 1.43B | 1.38B |
| Gross Profit | 609M | 625M | 692M | 663M | 633M |
| Operating Income | 279M | 265M | 279M | 226M | 145M |
| EBITDA | - | -167M | 374M | 274M | 225M |
| Net Income | -190M | -350M | 174M | 92.4M | 96.2M |
| EPS | -1.29 | -2.36 | 1.17 | 0.62 | 0.65 |
| Balance Sheet | |||||
| Total Assets | 2.43B | 2.72B | 2.84B | 2.57B | 2.62B |
| Total Liabilities | 3.06B | 1.23B | 1.15B | 978M | 927M |
| Shareholders' Equity | -656M | 1.47B | 1.68B | 1.58B | 1.69B |
| Cash & Short-term Investments | 609M | 722M | 619M | 421M | 438M |
| Cash Flow | |||||
| Operating Cash Flow | 164M | 234M | 249M | 108M | 144M |
| Capital Expenditure | 28.0M | 48.0M | 45.6M | 81.2M | 33.8M |
| Free Cash Flow | 136M | 186M | 203M | 26.6M | 110M |
| Ratios | |||||
| ROE | - | -23.8% | 10.3% | 5.9% | 5.7% |
| ROA | -7.8% | -12.9% | 6.1% | 3.6% | 3.7% |
| Net Profit Margin | -14.7% | -27.9% | 12.3% | 6.5% | 7.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Gaush Meditech Ltd dividends
Gaush Meditech Ltd has not paid dividends in the last 5 fiscal years.
Who owns Gaush Meditech Ltd
- Insiders 50.87%
- Institutions 12.39%
- Public & others 36.75%
- Shares outstanding 148M
- Free float 48.3M
Gaush Meditech Ltd company profile
- Company name
- Gaush Meditech Ltd
- Ticker
- F7Y.F
- ISIN
- KYG3902N1051
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 890
- Fiscal year end
- December
- Address
- Building A, Zhonghui Plaza, Beijing, China
- Phone
- 86 10 5978 6878
- Website
- gaush.com
About Gaush Meditech Ltd
Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. The company was founded in 1998 and is headquartered in Beijing, China.
Gaush Meditech Ltd management
8- Mr. Tieta GaoExecutive Chairman · born 1965
- Mr. Xinwei LiuExecutive Director & CEO · born 1982
- Mr. Jianjun ZhangHonorary President & Executive Director · born 1964
- Ms. Wenqi LiCFO & Executive Director · born 1974
- Mr. Xinli ZhaoExecutive Director & Chief Compliance Officer · born 1967
- Dr. Alexey Nikolaevich SimonovChief Technology Officer · born 1972
- Ms. Shui Bing Leung A.C.S.Joint Company Secretary · born 1977
- Mr. Bo ZhangJoint Company Secretary · born 1986